What is Myosin Therapeutics worth?
$30.0Mlast known valuation
Myosin Therapeutics last raised $3.0M in its Seed Round (Dec 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Myosin Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2022 | Seed Round | $3.0M | ▮ | ▮ |
How Myosin Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Myosin Therapeutics, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Myosin Therapeutics worth?
- Myosin Therapeutics's implied valuation is $30.0M, based on the PA Mark composite price of about $1 per share as of Sep 2026.
- How much has Myosin Therapeutics raised?
- Myosin Therapeutics has raised $6.9M in total funding across 1 recorded rounds.
- When did Myosin Therapeutics last raise?
- Myosin Therapeutics last raised in Dec 2022 (Seed Round), raising $3.0M.